The new Flash Glucose Monitoring System enables patients to wear the sensor for up to 14 days compared with the existing FreeStyle Libre System that was approved for 10-day wear.

The FreeStyle Libre 14-day system is also estimated to save about 50% in average annual medical costs for people with severe hypoglycemia (low blood sugar), according to the study. For people with ...

The Freestyle Libre 14 day is now the longest-lasting self-applied continuous glucose sensing technology available and allows the used to wear the sensor for up to 14 days with high accuracy.

Abbott’s 14-day Freestyle Libre continuous glucose monitor (CGM) has been approved by the FDA, giving US patients with diabetes access to technology that has been used in Europe for years.

ABBOTT PARK, Ill., April 8, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the FreeStyle Libre 14 day system, the world's leading 3 continuous glucose monitoring (CGM) technology ...

The FreeStyle Libre 3 system is the most accurate 14-day continuous glucose monitor1, with readings sent directly to a smartphone every minute.2 Designed for access and affordability, the ...

(RTTNews) - Abbott (ABT) said late-breaking clinical data showed the FreeStyle Libre 3 system has an overall mean absolute relative difference (MARD) of 7.9%, making it the first and only 14-day ...

FreeStyle Libre 14 day system: Failure to use FreeStyle Libre 14 day system as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision ...

Abbott initiated a voluntary medical device correction in February on its FreeStyle Libre, FreeStyle Libre 14 day and FreeStyle Libre 2 Readers in the US because of reports from some users that ...